Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide

We previously evaluated Wilms’ tumor gene 1 (WT1) peptide vaccination in a large number of patients with leukemia or solid tumors and have reported that HLA‐A*24:02 restricted, 9‐mer WT1‐235 peptide (CYTWNQMNL) vaccine induces cellular immune responses and elicits WT1‐235‐specific cytotoxic T lympho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Oji, Yusuke, Hashimoto, Naoya, Tsuboi, Akihiro, Murakami, Yui, Iwai, Miki, Kagawa, Naoki, Chiba, Yasuyoshi, Izumoto, Shuichi, Elisseeva, Olga, Ichinohasama, Ryo, Sakamoto, Junichi, Morita, Satoshi, Nakajima, Hiroko, Takashima, Satoshi, Nakae, Yoshiki, Nakata, Jun, Kawakami, Manabu, Nishida, Sumiyuki, Hosen, Naoki, Fujiki, Fumihiro, Morimoto, Soyoko, Adachi, Mayuko, Iwamoto, Masahiro, Oka, Yoshihiro, Yoshimine, Toshiki, Sugiyama, Haruo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Tumor Immunology and Microenvironment
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089562/
https://ncbi.nlm.nih.gov/pubmed/27170523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados